Was CNBC totally unprepared for a contest?

CNBC.com is again sponsoring an investor contest designed to gather
personal information.

OK, you have to give up something to enter contests with significent prizes.

BUT.

AFTER they collect your information (either for the use of their
direct advertisers or to sell) it turns out that they weren't prepared
for the web traffic and I found it impossible to log on for 20
minutes, then, after 45 minutes, I was still unable to actually enter
the contest - that put me a day behind anyone who had been able to
enter and essentially out of the running.

I consider this fraud.

What do you think? Would you ever enter personal information to enter
a CNBC investment contest? I certainly hope not but gamble your
personal data at your own risk.

--

www.newmedicineonline.com

The trouble with learning things the hard way is that sometimes you
only get the one fatal lesson. - jm

Comments

Post a Comment

Popular posts from this blog

Climate Change, Too Late To Beg Politicians - Time To Follow The Pentagon And Begin Preparation For The Inevitable.

 As for climate change, I worked on it for decades even in an official capacity as an emergency management coordinator. It is too late to change what will happen by 2050. Politicians simply can't move fast enough, even countries which agreed with the Paris agreement have totally failed to  to meet the goals they agreed to. It is time to stop wasting time, money, and effort on fighting short term climate change and focus our energy on preparing for inevitable financial and social changes we or our descendants will face. Working to make long-term changes would be  useful but that will occur naturally as Red states are washed away (GRIN). I wrote a book about this and am working on the second volume now. "Preparing for Climate Change  Coastal flooding will cost the U.S. billions of dollars within two decades." . second edition ebook  https://www.amazon.com/gp/product/B07TYTG6ZC [ excerpt below ] As far back as 2014 the U.S. military saw climate change as the  biggest strateg
Read more

Does Anyone Still Answer Their Phone?

Today I did my weekly cleanup of phone messages. I change my phone number every two years but the nonsense calls build up to an intolerable level after about 14 months. Today there were 27 saved messages from unanswered calls, some from humans (sort of), a couple from someone speaking Hindustani, and some from computers, all from three companies selling things I would never buy. I live in the country and we know what to do with door-to-door salesmen. Between large hungry dogs and shotguns paired with a backhoe. If I ever answered one of these calls I would still be cursing the caller as my BP went up and up so I never, NEVER answer my phone. There were 7 non sales calls, all from my insurance company, UPMC which is a great insurance plan EXCEPT FOR THE VOLUME OF NONSENSE CALLS they force on me almost daily. No, I do not want to join your conference call about "how to make the most of staying at home" OR the very latest news about COVID or COVID vaccines, only about 4 days beh
Read more

Experimental Anti-Viral MK-4482 To Treat COVID (Rocky Mountain)

 Initial animal tests of a brand new anti-viral medicine has shown what it may treat or even prevent COVID-19. This could be the magic bullet which could defeat the anti-vaXXers and even the mutations. MK-4482 shows potential to prevent and treat SARS-CoV-2 infection. In a press release the NIH just published this information within the hour. " The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists. SARS-CoV-2 is the virus that causes COVID-19. MK-4482, delivered orally, is now in human clinical trials. Remdesivir, an antiviral drug already approved by the U.S. Food and Drug Administration for use against COVID-19, must be provided intravenously, making its use primarily limited to clinical settings. In their study, published in the journal  Nature Communications , the scientists found MK-4482 treatment effect
Read more